Digital Content 
NEWS #PharmaBuzz
26 Sep 2025
// BIOSPACE
https://www.biospace.com/fda/fda-approves-crinetics-once-daily-acromegaly-treatment
26 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orsini-selected-as-specialty-pharmacy-partner-for-crinetics-palsonify-paltusotine-302567807.html
13 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/13/3114463/0/en/Crinetics-to-Present-New-Long-Term-Data-Demonstrating-Durable-Control-of-Once-Daily-Oral-PALSONIFY-Paltusotine-in-Acromegaly-at-ENDO-2025.html
30 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/30/3107872/0/en/Crinetics-to-Showcase-the-Next-Generation-of-Endocrinology-Innovation-at-ENDO-2025-with-Eight-Presentations-From-its-Deep-Pipeline.html
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050988/0/en/Crinetics-Pharmaceuticals-Announces-European-Medicines-Agency-EMA-Validation-of-Marketing-Authorization-Application-MAA-and-Orphan-Drug-Designation-ODD-for-Paltusotine-in-Acromegal.html
09 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/09/2993693/0/en/Crinetics-Announces-FDA-Acceptance-of-New-Drug-Application-for-Paltusotine-for-Adult-Patients-with-Acromegaly.html
Share 